Michael B. McNulty
Plus aucun poste en cours
Profil
Michael B.
McNulty worked as a Director at Transgenomic, Inc. from 2009 to 2010.
He was the General Manager-Molecular Diagnostics at Agilent Technologies, Inc. from 2004 to 2010.
Prior to that, he was the Chief Compliance Officer & VP-Clinical Laboratory at Berkeley HeartLab, Inc. in 2004.
In 2010, he briefly served as the Chief Operating Officer at Response Genetics, Inc. He also worked as the Vice President & General Manager at SmithKline Beecham Clinical Laboratories.
McNulty received his undergraduate degree from San Jose State University.
Anciens postes connus de Michael B. McNulty
| Sociétés | Poste | Fin |
|---|---|---|
Transgenomic, Inc.
 Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Directeur/Membre du Conseil | 29/12/2010 |
| RESPONSE GENETICS, INC | Directeur des opérations | 26/10/2010 |
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/07/2010 |
Berkeley HeartLab, Inc.
 Berkeley HeartLab, Inc. Medical/Nursing ServicesHealth Services Berkeley HeartLab Inc. operates as a cardiovascular healthcare company. It provides cardiovascular disease management tools and services, with focus on the secondary prevention market. The company was founded by Robert H. Superko in 1995 and is headquartered in CA. | Directeur Technique/Scientifique/R&D | 01/01/2004 |
SmithKline Beecham Clinical Laboratories
 SmithKline Beecham Clinical Laboratories Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, SmithKline Beecham Clinical Laboratories is a British company that provides diagnostic services, testing, and information. The company is based in Heston, UK. | Corporate Officer/Principal | - |
Formation de Michael B. McNulty
| San Jose State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RESPONSE GENETICS, INC | Health Technology |
| AGILENT TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
SmithKline Beecham Clinical Laboratories
SmithKline Beecham Clinical Laboratories Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, SmithKline Beecham Clinical Laboratories is a British company that provides diagnostic services, testing, and information. The company is based in Heston, UK. | Commercial Services |
Berkeley HeartLab, Inc.
Berkeley HeartLab, Inc. Medical/Nursing ServicesHealth Services Berkeley HeartLab Inc. operates as a cardiovascular healthcare company. It provides cardiovascular disease management tools and services, with focus on the secondary prevention market. The company was founded by Robert H. Superko in 1995 and is headquartered in CA. | Health Services |